Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Resveratrol-loaded nanoparticles show promise for lung cancer treatment.

SOX2 is crucial for skin cell function and hair growth, and it plays a role in skin cancer and wound healing.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Cedrol may be an effective treatment for colorectal cancer.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Epidermal Growth Factor helps hair follicle cells grow and move by activating a specific cell signaling pathway.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Dermoscopy has improved skin cancer diagnosis and has expanding applications in dermatology, but requires staying updated with new research and techniques.

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Ozone therapy might improve cancer treatment and reduce its side effects.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

The photolyase-based device significantly changed the size and heat of potential skin cancer areas in patients.

A woman died from cancer that spread from a long-standing cyst on her abdomen.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.